compounded tirzepatide going away GLP-1 - Semaglutide & Compounded Tirzepatide Explained: Key Facts

Most patients achieve significant and sustainable weight loss before reaching this peak dose

Epidemiology Incidence is about 10-15% in women at an average age of 40

Compounded oral GLP-1s are formulated to deliver similar active ingredients as approved injectables, though clinical evidence on compounded versions is more limited

Clarity for Your Health Goals Take the next step toward your weight goals with a plan designed around your needs and medical history

The same disciplined assessment guides the other conditions treated at the centre, including myositis, CIDP, NMOSD and lupus

The authors also thank Curtin University, School of Pharmaceutical and Biomedical Sciences, and Faculty of Health, Torrens University Australia for research support